Compare KTTA & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KTTA | IHT |
|---|---|---|
| Founded | 2020 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1M | 15.2M |
| IPO Year | 2021 | 1995 |
| Metric | KTTA | IHT |
|---|---|---|
| Price | $0.55 | $1.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 216.1K | 16.7K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | ★ 77.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $486,559.00 | ★ $7,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3130.37 | 1.33 |
| 52 Week Low | $0.28 | $0.95 |
| 52 Week High | $2.06 | $4.24 |
| Indicator | KTTA | IHT |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 26.10 |
| Support Level | $0.54 | $1.26 |
| Resistance Level | $0.61 | $1.27 |
| Average True Range (ATR) | 0.04 | 0.14 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 92.85 | 4.08 |
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.